Ambipar Participacoes e Empreendimentos SA
BOVESPA:AMBP3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.05
268.51
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
AMBP3 Price Targets Summary
Ambipar Participacoes e Empreendimentos SA
According to Wall Street analysts, the average 1-year price target for AMBP3 is 18.77 BRL with a low forecast of 14.34 BRL and a high forecast of 22.05 BRL.
Price Targets
Revenue
Forecast
Revenue Estimate
Ambipar Participacoes e Empreendimentos SA
For the last 5 years the compound annual growth rate for Ambipar Participacoes e Empreendimentos SA's revenue is 66%. The projected CAGR for the next 4 years is 15%.
Operating Income
Forecast
Operating Income Estimate
Ambipar Participacoes e Empreendimentos SA
For the last 5 years the compound annual growth rate for Ambipar Participacoes e Empreendimentos SA's operating income is 73%. The projected CAGR for the next 3 years is 14%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMBP3's stock price target?
Price Target
18.77
BRL
According to Wall Street analysts, the average 1-year price target for AMBP3 is 18.77 BRL with a low forecast of 14.34 BRL and a high forecast of 22.05 BRL.
What is Ambipar Participacoes e Empreendimentos SA's Revenue forecast?
Projected CAGR
15%
For the last 5 years the compound annual growth rate for Ambipar Participacoes e Empreendimentos SA's revenue is 66%. The projected CAGR for the next 4 years is 15%.
What is Ambipar Participacoes e Empreendimentos SA's Operating Income forecast?
Projected CAGR
14%
For the last 5 years the compound annual growth rate for Ambipar Participacoes e Empreendimentos SA's operating income is 73%. The projected CAGR for the next 3 years is 14%.